Clinical Trials Logo

Intraoperative Bleeding clinical trials

View clinical trials related to Intraoperative Bleeding.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05867342 Completed - Clinical trials for Intraoperative Bleeding

Effects of Adrenaline Infiltration on Surgical Field of View in Endoscopic Sinus Surgery

Start date: May 12, 2017
Phase: Phase 4
Study type: Interventional

In endoscopic sinus surgery a clear surgical field of view is a very important aspect for good surgical outcome. This study is to evaluate the preoperative preparation to acquire best surgical field of view by comparing between the use of topical adrenaline and the use of combination of topical adrenaline with infiltration of 1% lidocaine with adrenaline in patients scheduled for endoscopic sinus surgery for rhinosinusitis.

NCT ID: NCT04188184 Completed - Clinical trials for Intraoperative Bleeding

Tranexamic Acid Versus Epinephrine During Exploratory Tympanotomy

Start date: December 4, 2019
Phase: N/A
Study type: Interventional

Exploratory tympanotomy is surgical access to the middle ear, made for diagnosis and management of unexplained conductive hearing loss, performed under an oto-microscope across the external auditory canal after tympanic membrane elevation to explore the middle ear structures

NCT ID: NCT04168879 Completed - Clinical trials for Postoperative Delirium

Sphenopalatine Ganglion Block for Nasal Surery

Start date: November 10, 2021
Phase: N/A
Study type: Interventional

nasal surgery carries many perioperative challenges, intraoperative bleeing and its effect on surgical field i the main intraoperative concern an postoperative agitation and its serious complications is the main postoperative challenge.

NCT ID: NCT03820206 Completed - Clinical trials for Intraoperative Bleeding

The Value of Tranxemic Acid to Reduce Intraoperative Blood Loss During Elective Cesarean Sections in High Risk Women

Start date: January 31, 2019
Phase: N/A
Study type: Interventional

A full medical history will be obtained from all participants. Obstetric ultrasonography and laboratory tests will be performed.According to group assignment, either 1 g(10 mL) tranexamic acid stored in a dry container at 15 °C-30 °C) diluted in 20 mL of 5% glucose or 30 mL of 5% glucose will be slowly administered intravenously 15 minutes before skin incision over a 5-minute period. Following delivery, patients in both groups will receive an intravenous bolus of 5 IU oxytocin , 1 mL(0.2 mg) intramuscular ergometrine , and 20 IU oxytocin in 500 mL lactated Ringer's solution(infused at a rate of 125 mL/h)

NCT ID: NCT03047070 Completed - Clinical trials for Intraoperative Bleeding

Lidocaine in ERAS for FESS

Start date: February 9, 2017
Phase: Phase 2
Study type: Interventional

Functional endoscopic sinus surgery (FESS) is a commonly performed procedure. It is known that bleeding during FESS can affect directly to the visibility of safe landmarks and surgical outcomes.

NCT ID: NCT02229292 Completed - Clinical trials for Intraoperative Bleeding

Prevention of Intraoperative Bleeding and Postoperative Swelling in Orthognathic Surgery Through the Use of Tranexamic Acid

TXA2014-15
Start date: August 19, 2014
Phase: Phase 4
Study type: Interventional

Purpose of the study: - To evaluate the effect of tranexamic acid (TXA) of intraoperative blood loss in patients subjected to bi-maxillary orthognathic surgery - To evaluate the potential effect of TXA on fibrin structure - To evaluate the potential effect of TXA of binding of plasminogen to fibrin - To evaluate the potential effect of TXA on postoperative edema formation. Hypothesis: H0: Intraoperative bleeding cannot be significantly reduced by preoperative administration of tranexamic acid H0,1: Postoperative edema cannot be significantly reduced by preoperative administration of tranexamic acid

NCT ID: NCT01891461 Completed - Clinical trials for Intraoperative Bleeding

Study to Compare the Addition of Floseal to Our Standard of Care to Control Post Operative Bleeding in TKR

Start date: January 2012
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare Floseal to our standard of care (SOC) to decrease intraoperative and immediate post-operative bleeding.

NCT ID: NCT01656759 Completed - Osteoarthritis Clinical Trials

Use of a Novel Fibrin Sealant in Total Knee Arthroplasty

Start date: May 2012
Phase: Phase 2/Phase 3
Study type: Interventional

Applying a fibrin spray, after knee device implantation, will help in reducing patient blood loss and decrease the drop in both hemoglobin and hematocrit levels. Also, with decreased blood loss there should be a reduced need for blood transfusions.

NCT ID: NCT01651806 Completed - Osteoarthritis Clinical Trials

Weighted Versus Uniform Dose of Tranexamic Acid in Patients Undergoing Primary, Knee Arthroplasty

Start date: May 2012
Phase: Phase 2/Phase 3
Study type: Interventional

Hypotheses: Primary - A weighted dose of 20 mg/kg of tranexamic acid will be more efficacious than a single uniform dose of 1 gram in primary total knee arthroplasty (TKA) cases. This includes having a greater impact on decreasing blood loss without increasing the occurrence of adverse thromboembolic events in patients undergoing primary, elective total knee arthroplasty. Secondary - TA will decrease blood loss more effectively in women than in men undergoing this procedure.